Cargando…
Recombinant and Plasma-Purified Human C1 Inhibitor for the Treatment of Hereditary Angioedema
BACKGROUND: Agents for prophylaxis of hereditary angioedema (HAE) have been available in the United States for several decades, but their usefulness is limited by side effects and they cannot be used at all in some patients. No agents have been available in the United States to specifically treat ac...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666149/ https://www.ncbi.nlm.nih.gov/pubmed/23282867 http://dx.doi.org/10.1097/1939-4551-3-S3-S29 |